Biochemical Crosslinking for Spinal Disc Mechanical Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for collagenous tissue degradation, such as in intervertebral discs and scoliosis, are inadequate in preventing progressive spinal deformities and degeneration, with existing methods like bracing being ineffective and invasive surgeries carrying significant risks and complications.
Innovation Solution
A method involving the use of cross-linking agents like methylglyoxal, genipin, proanthrocyanidin, transglutaminase, and L-threose to induce cross-linking in native collagenous tissues within the body, enhancing the mechanical stability and permeability of spinal discs through targeted injections or delivery systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bracing is used to treat spinal deformities, then some mechanical support is provided, but it is ineffective and associated with high patient non-compliance
Solution Approach 1:
The patent replaces the mechanical bracing system with a biochemical cross-linking therapy. Cross-linking agents are introduced to chemically modify and strengthen collagenous tissues within the spinal disc, providing internal structural reinforcement rather than external mechanical support. This substitution eliminates the need for continuous external bracing and significantly improves patient compliance.
Solution Approach 2:
The cross-linking therapy enables the spinal disc to strengthen itself from the inside. The cross-linking agents catalyze the formation of collagen cross-links within the tissue, allowing the disc to autonomously improve its mechanical properties without requiring external devices or continuous patient effort. This self-reinforcing mechanism ensures long-term effectiveness independent of patient compliance.
2Reliability
If invasive surgery is performed to correct spinal deformities, then structural correction is achieved, but it carries significant risks and complications
Solution Approach 1:
The patent replaces invasive surgical mechanical correction with a non-invasive biochemical process. Instead of cutting and repositioning tissues surgically, cross-linking agents are introduced to chemically strengthen the existing collagenous matrix, achieving structural correction through molecular-level changes rather than macroscopic surgical intervention.
Solution Approach 2:
Cross-linking agents serve as intermediary substances that facilitate tissue strengthening without direct surgical manipulation. These agents penetrate the spinal disc and catalyze the formation of collagen cross-links, acting as a chemical mediator that achieves structural reinforcement without the trauma and complications of invasive surgery.
3Strength
If cross-linking agents are introduced to stabilize spinal discs, then fatigue resistance and mechanical stability are improved, but the process requires precise control of chemical conditions
Solution Approach 1:
The patent employs cross-linking agents that function optimally at physiological pH ranges (7.0-7.5), allowing the treatment to proceed under normal body conditions without requiring complex external control systems. The chemical reactions are triggered and regulated by the body's own physiological environment, simplifying the delivery and control mechanisms while achieving enhanced fatigue resistance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach stabilizes spinal discs, reduces pain, and prevents further deformation or degeneration without surgery, improving fatigue resistance and hydraulic permeability, thus offering a non-surgical, minimally invasive solution for degenerative disc disease and scoliosis.
Implementation Method 1
A method involving the use of cross-linking agents like methylglyoxal, genipin, proanthrocyanidin, transglutaminase, and L-threose to induce cross-linking in native collagenous tissues within the body
Implementation Method 2
enhancing the mechanical stability and permeability of spinal discs through targeted injections or delivery systems
Data Source
AI summary
Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.